Next, the prognostic value of CDK4 and EXT2 for LGG and GBM was further assessed in the TCGA and GTEx database cohorts through Gene Expression Profiling Interactive Analysis 2 (GEPIA2). The gene discussed is CDK4; the disease is glioblastoma.